NHS, Alzheimer's

Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare the new treatment for the disease safe for use but the rationing body for the health service will immediately rule that it is too expensive for NHS patients.
UK's NHS to block Eli Lilly's Alzheimer's drug on Wednesday, Telegraph reports
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too expensive for NHS patients, the Telegraph reported on Tuesday.
'Best ever' Alzheimer's drug 'set to be blocked for NHS use' due to cost pressures
An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by pharmaceutical giant Eli Lilly, is a targeted antibody drug which slows down the early stages of Alzheimer's.
NHS patients to miss out on benefits of new Alzheimer’s drugs, experts warn
NHS patients are set to miss out on new Alzheimer’s disease drugs, experts warn.Earlier this year lecanemab, the first treatment found to slow the disease’s progression, was licensed by regulators.However,
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
On Monday, Eli Lilly And Co (NYSE:LLY) announced plans to boost its presence in the U.K., following a collaboration with the U.K. government that was revealed at the International Investment Summit. The global pharmaceutical giant is set to invest in a new Gateway Lab in the U.
Lilly Alzheimer's drug not to be covered by U.K.'s NHS: report
U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early Alzheimer’s disease because it’s too expensive. Read more here.
Science Daily2d
Alzheimer's News
Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...
Dementia expert makes bombshell '10 years' Alzheimer's cure claim but it relies on one thing
A leading dementia expert has expressed optimism that a cure for Alzheimer's disease will be discovered within the next decade. Professor Craig Ritchie also predicts that significant advancements in ...
UPI5d
Alzheimer's disease might damage brain in two phases
Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly and silently appears to lay the groundwork for a second, more widely ...
Science Daily3d
Dementia News
Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...
Newsweek7d
Alzheimer's: Simple Drug Change Could Save Medicare Hundreds of Millions
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication. Alzheimer's affects roughly 5.8 million Americans, according to the Centers for Disease ...
WebMD13d
Risk Factors for Alzheimer's Disease
What Causes Alzheimer’s Disease? Researchers don't know exactly what causes Alzheimer’s disease. Many things are thought to be involved. But as scientists have learned more about the condition ...
Healthline7d
Does Aluminum Cause Alzheimer’s?
Studies have not found evidence that aluminum contributes to Alzheimer’s disease development. But research is ongoing, and you could be a part of it. Alzheimer’s is a progressive disease that ...
Why thousands of dementia sufferers are being denied the new miracle drug
In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...